FI761863A - - Google Patents

Info

Publication number
FI761863A
FI761863A FI761863A FI761863A FI761863A FI 761863 A FI761863 A FI 761863A FI 761863 A FI761863 A FI 761863A FI 761863 A FI761863 A FI 761863A FI 761863 A FI761863 A FI 761863A
Authority
FI
Finland
Application number
FI761863A
Other languages
Finnish (fi)
Other versions
FI55852C (fi
FI55852B (fi
Inventor
Welf Von Daehne
Poul Rodbroe Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26989/75A external-priority patent/GB1523803A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI761863A publication Critical patent/FI761863A/fi
Application granted granted Critical
Publication of FI55852B publication Critical patent/FI55852B/fi
Publication of FI55852C publication Critical patent/FI55852C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
FI761863A 1975-06-25 1976-06-24 Foerfarande foer framstaellning av nya antimikrobiellt verkande fusidinsyraderivat FI55852C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26989/75A GB1523803A (en) 1975-06-25 1975-06-25 16-ethers of fusidic acid derivatives
GB4622975 1975-11-07

Publications (3)

Publication Number Publication Date
FI761863A true FI761863A (de) 1976-12-26
FI55852B FI55852B (fi) 1979-06-29
FI55852C FI55852C (fi) 1979-10-10

Family

ID=26258548

Family Applications (1)

Application Number Title Priority Date Filing Date
FI761863A FI55852C (fi) 1975-06-25 1976-06-24 Foerfarande foer framstaellning av nya antimikrobiellt verkande fusidinsyraderivat

Country Status (18)

Country Link
JP (1) JPS523051A (de)
AT (1) AT345979B (de)
AU (1) AU500027B2 (de)
CA (1) CA1064906A (de)
DE (1) DE2628360C2 (de)
DK (1) DK143905C (de)
ES (1) ES449257A1 (de)
FI (1) FI55852C (de)
FR (1) FR2315296A1 (de)
GR (1) GR60362B (de)
IE (1) IE43478B1 (de)
IT (1) IT1062245B (de)
LU (1) LU75239A1 (de)
NL (1) NL7606983A (de)
NZ (1) NZ181107A (de)
PT (1) PT65261A (de)
SE (1) SE7607322L (de)
SU (1) SU799670A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581335A (en) * 1976-07-05 1980-12-10 Leo Pharm Prod Ltd 16-s-acyl derivatives of fusidic acid
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)

Also Published As

Publication number Publication date
LU75239A1 (de) 1977-03-16
SE7607322L (sv) 1976-12-26
FI55852C (fi) 1979-10-10
FR2315296B1 (de) 1980-11-07
IT1062245B (it) 1983-09-20
DK285776A (da) 1976-12-26
JPS6350360B2 (de) 1988-10-07
ES449257A1 (es) 1977-12-16
IE43478L (en) 1976-12-25
CA1064906A (en) 1979-10-23
JPS523051A (en) 1977-01-11
AU1525076A (en) 1978-01-05
PT65261A (en) 1976-07-01
AU500027B2 (en) 1979-05-10
DK143905C (da) 1982-04-19
FI55852B (fi) 1979-06-29
SU799670A3 (ru) 1981-01-23
NZ181107A (en) 1978-11-13
DK143905B (da) 1981-10-26
PT65261B (de) 1977-12-07
GR60362B (en) 1978-05-19
NL7606983A (nl) 1976-12-28
ATA438776A (de) 1978-02-15
AT345979B (de) 1978-10-10
FR2315296A1 (fr) 1977-01-21
IE43478B1 (en) 1981-03-11
DE2628360A1 (de) 1977-01-13
DE2628360C2 (de) 1986-11-06

Similar Documents

Publication Publication Date Title
DK137076A (de)
FR2315296B1 (de)
JPS51128983U (de)
JPS5179208U (de)
JPS5219850U (de)
JPS5142382Y1 (de)
JPS51118222U (de)
JPS51127095U (de)
JPS51140886U (de)
JPS51148398U (de)
JPS5234926U (de)
JPS5268393U (de)
JPS5191959U (de)
JPS51104859U (de)
JPS51123750U (de)
CH595058A5 (de)
BG22245A1 (de)
CH581877A5 (de)
CH579442A5 (de)
CH586541A5 (de)
BG23412A1 (de)
CH594132A5 (de)
BG22902A1 (de)
CH587714A5 (de)
BG22694A1 (de)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S